Kubeczko, M., d'Amico, A., Chrabański, O., Mianowska-Malec, M., Świderska, K., Polakiewicz-Gilowska, A., Leśniak, A., Łanoszka, B., Chomik, K., Grandys, B., Lisovska, N., Stobiecka, E., Simek, J., Pyciński, B., Chmielik, E., Handkiewicz-Junak, D., Prat, A., Jarząb, M. (2025). Positron-emission tomography utility for progression-free survival prediction in HER2-positive advanced breast cancer patients treated with pertuzumab, trastuzumab, and docetaxel.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e13012